Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
NCT07290803 · View on ClinicalTrials.gov ↗
Study Summary
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions. The study will be conducted across 10 countries in 4 different geographical regions, with a follow-up period of 5 years.
Conditions Studied
Study Locations (20)
California
- Kern Research, Inc.- Site Number : 8400047 — Bakersfield
- Center for Dermatology Clinical Research- Site Number : 8400014 — Fremont
- Dermatology Research Associates - Los Angeles- Site Number : 8400020 — Los Angeles
- Northridge Clinical Trials, LLC- Site Number : 8400009 — Northridge
- Sunwise Clinical Research, LLC.- Site Number : 8400010 — Oakland
- Empire Clinical Research, LLC- Site Number : 8400007 — Pomona
- University Clinical Trials- Site Number : 8400019 — San Diego
Michigan
- David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017 — Ann Arbor
- Oakland Hills Dermatology- Site Number : 8400042 — Auburn Hills
- Great Lakes Research Group - Bay City- Site Number : 8400052 — Bay City
- The Derm Institute of West Michigan- Site Number : 8400025 — Caledonia
- Michigan Dermatology Institute - Waterford- Site Number : 8400013 — Waterford
Alabama
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006 — Birmingham
- River Region Dermatology and Laser- Site Number : 8400041 — Montgomery
Florida
- St. Jude Clinical Research- Site Number : 8400049 — Doral
- Ziaderm Research, LLC- Site Number : 8400021 — North Miami Beach
Georgia
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034 — Macon
- Georgia Skin & Cancer Clinic- Site Number : 8400023 — Savannah
Arizona
- San Tan Allergy & Asthma- Site Number : 8400031 — Gilbert
Colorado
- Western States Clinical Research, Inc.- Site Number : 8400051 — Wheat Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2034-01-30 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07290803
The ClinicalTrials.gov registry entry for NCT07290803 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 275 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT07290803 reports 20 study locations spanning 7 distinct geographic areas — top geographies include California, Michigan, Alabama. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT07290803 about?
NCT07290803 is a clinical study titled "This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment". The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. A...
What is the current status of trial NCT07290803?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-11-17. Estimated completion is 2034-01-30.
What conditions does trial NCT07290803 study?
This clinical trial studies the following conditions: Atopic Dermatitis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT07290803?
This trial is sponsored by Sanofi, which has 275 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT07290803 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.